TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24726639

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 22924169

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.30 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.15 mg/kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 20332353

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 5145

Group type: COMPARATOR
Intervention: Diabetes Support and Education (DSE)
Number of subjects: 5145

Group type: COMPARATOR
Intervention: DSE (optimal care goals)
Number of subjects: 5145

Group type: EXPERIMENTAL
Intervention: ILI (optimal care)
Number of subjects: 5145
Study: 18039205

Group type: EXPERIMENTAL
Intervention: High MAP group (mean arterial pressure target during CPB was 80 mmHg)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Custom MAP group (mean arterial pressure target determined by patients' pre-bypass MAP)
Number of subjects: 412
Study: 16244842

Group type: EXPERIMENTAL
Intervention: 0.8% isoflurane with 2 mg/kg succinylcholine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1.4% isoflurane with 2 mg/kg succinylcholine
Number of subjects: 20
Study: 12081985

Group type: EXPERIMENTAL
Intervention: Coronary stenting
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Thrombolysis
Number of subjects: 243

Group type: COMPARATOR
Intervention: No resolution
Number of subjects: 243
Study: 9472058

Group type: EXPERIMENTAL
Intervention: Iodixanol 270 mgI/ml
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Iodixanol 320 mgI/ml
Number of subjects: 72

Group type: COMPARATOR
Intervention: Iohexol 300 mgI/ml
Number of subjects: 72
Study: 7896157

Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 60
Study: 2468975

Group type: EXPERIMENTAL
Intervention: Diltiazem (90 mg every 6 h for up to 14 days)
Number of subjects: 576

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 576
Study: 935972

Group type: EXPERIMENTAL
Intervention: Metiamide (histamine H2-receptor antagonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propantheline (anticholinergic)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of Metiamide and Propantheline
Number of subjects: 0
Study: 6987023

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 100 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 29339109

Group type: EXPERIMENTAL
Intervention: Bitter gourd (2.5g powder daily)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Cucumber juice (placebo)
Number of subjects: 52
Study: 26651352

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral conjoint therapy for PTSD (CBCT for PTSD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 40
Study: 24684245

Group type: EXPERIMENTAL
Intervention: Thyroid hormone (thyroxine, T4) supplementation at doses of 4, 8, and 16 μg/(kg · day), bolus or continuous administration
Number of subjects: 166

Group type: COMPARATOR
Intervention: Iodine only
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166
Study: 22820713

Group type: EXPERIMENTAL
Intervention: Percutaneous minimal internal fixation using one or more lag screws and Ilizarov external fixation
Number of subjects: 324
Study: 19945906

Group type: EXPERIMENTAL
Intervention: Lumbar posteroanterior mobilisations at 2 Hz
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lumbar posteroanterior mobilisations at 1 Hz
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Quasi-static lumbar posteroanterior mobilisations
Number of subjects: 30
Study: 17650168

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 40
Study: 15848674

Group type: EXPERIMENTAL
Intervention: tacrolimus+daclizumab+MMF (study arm)
Number of subjects: 39

Group type: COMPARATOR
Intervention: tacrolimus+steroids+MMF (control arm)
Number of subjects: 39
Study: 14700085

Group type: EXPERIMENTAL
Intervention: sorbitol/carbamide gum
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: sorbitol gum
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: xylitol gum
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: placebo gum
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: no gum
Number of subjects: 602
Study: 9539412

Group type: EXPERIMENTAL
Intervention: Metrifonate
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 7891046

Group type: EXPERIMENTAL
Intervention: Encapsulated K85 (n = 28)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Corn oil (n = 29)
Number of subjects: 57
Study: 1978468

Group type: EXPERIMENTAL
Intervention: Remoxipride (mean daily dose: 363 mg)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Haloperidol (mean daily dose: 9 mg)
Number of subjects: 71
Study: 608798

Group type: EXPERIMENTAL
Intervention: Screening group (attended two screening sessions)
Number of subjects: 7229

Group type: COMPARATOR
Intervention: Control group (received conventional medical care)
Number of subjects: 7229

Group type: EXPERIMENTAL
Intervention: Screening group
Number of subjects: 7229

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 7229
Study: 29799075

Group type: EXPERIMENTAL
Intervention: Permanent tacks (Protack™)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Absorbable tacks (Securestrap™)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Synthetic glue (Glubran™)
Number of subjects: 75
Study: 27028771

Group type: EXPERIMENTAL
Intervention: AC + PI (Adductor Canal block with Periarticular Infiltration)
Number of subjects: 151

Group type: COMPARATOR
Intervention: AC (Adductor Canal block only)
Number of subjects: 151

Group type: COMPARATOR
Intervention: PI (Periarticular Infiltration only)
Number of subjects: 151
Study: 24852500

Group type: EXPERIMENTAL
Intervention: EEG suppression (defined as >5 cumulative minutes of EEG suppression)
Number of subjects: 2662

Group type: COMPARATOR
Intervention: Non-suppressed cohort (≤5 min suppression)
Number of subjects: 2662

Group type: EXPERIMENTAL
Intervention: EEG suppression with MAP <55 mm Hg
Number of subjects: 2662

Group type: EXPERIMENTAL
Intervention: EEG suppression overall
Number of subjects: 2662

Group type: EXPERIMENTAL
Intervention: EEG suppression after matching and multivariable adjustment
Number of subjects: 2662
Study: 22536918

Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 19900349

Group type: EXPERIMENTAL
Intervention: Risperidone (2-6 mg)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Haloperidol (2-40 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Patients with SZ
Number of subjects: 26
Study: 18253955

Group type: EXPERIMENTAL
Intervention: Activated charcoal (AC) at a dose of 250 mg three times daily during irinotecan administration
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no activated charcoal)
Number of subjects: 22
Study: 16176339

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 12839320

Group type: EXPERIMENTAL
Intervention: Child Health Questionnaire (CHQ‐PF28) administered at 14 days after ED visit
Number of subjects: 732

Group type: EXPERIMENTAL
Intervention: Initial CHQ score obtained at the visit
Number of subjects: 732
Study: 10919300

Group type: EXPERIMENTAL
Intervention: 1 mg morphine intraarticularly
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 5 mg morphine intraarticularly
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 5 mg saline intraarticularly and morphine intravenously
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline both intraarticularly and intravenously
Number of subjects: 40
Study: 9014628

Group type: EXPERIMENTAL
Intervention: Impedance cardiography using the lateral spot (LS) electrode array and Sramek-Bernstein equation
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Impedance cardiography using the modified semi-circular (MSC) electrode array and Kubicek's equation
Number of subjects: 37

Group type: COMPARATOR
Intervention: Thermodilution (SVTD)
Number of subjects: 37
Study: 1488460

Group type: EXPERIMENTAL
Intervention: Behavioral family treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supportive family treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 2951818

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide + fenoterol (1 puff per 10 kg body weight, max 4 puffs; each puff contains 0.02 mg ipratropium bromide and 0.05 mg fenoterol)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: COMPARATOR
Intervention: No medication
Number of subjects: 30
Study: 29474803

Group type: EXPERIMENTAL
Intervention: Combined exercise training (CET: n = 13)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Taurine supplementation (TAU: n = 12)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Exercise training associated with taurine (CET+TAU: n = 11)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (CG: n = 12)
Number of subjects: 48
Study: 27753676

Group type: EXPERIMENTAL
Intervention: Z-track technique for intramuscular injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard technique of intramuscular injection
Number of subjects: 60
Study: 25002101

Group type: EXPERIMENTAL
Intervention: Jian-Wei-Qu-Tong Pills (JWQTP) high-dose group
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Jian-Wei-Qu-Tong Pills (JWQTP) low-dose group
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 240
Study: 22575316

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 1613

Group type: COMPARATOR
Intervention: Atorvastatin 80 mg
Number of subjects: 1613
Study: 21094364

Group type: EXPERIMENTAL
Intervention: Muscle functional electrical stimulation (FES) for 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional bicycle training for 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of FES and bicycle training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Post-intervention FMD values
Number of subjects: 0
Study: 18503515

Group type: EXPERIMENTAL
Intervention: Flap surgery plus guided tissue regeneration (e-PTFE membrane)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Flap surgery alone (control group)
Number of subjects: 30
Study: 15902961

Group type: EXPERIMENTAL
Intervention: Humanized anti-IL-6R monoclonal antibody (MRA), administered every 2 weeks for 12 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Single MRA infusion
Number of subjects: 100
Study: 12544160

Group type: EXPERIMENTAL
Intervention: Serial neuropsychological assessment before and after competition
Number of subjects: 18
Study: 10390003

Group type: EXPERIMENTAL
Intervention: Question prompt sheet provided before the consultation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Coaching in question-asking behaviour
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 8910759

Group type: EXPERIMENTAL
Intervention: rHuIFN‐beta 1a (6 MIU) i.v.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: rHuIFN‐beta 1a (6 MIU) i.m.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: rHuIFN‐beta 1a (6 MIU) s.c.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 12
Study: 1799900

Group type: EXPERIMENTAL
Intervention: Mental stress testing
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (non-reactive subjects)
Number of subjects: 82
Study: 6407315

Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nitroprusside
Number of subjects: 0
Study: 31926856

Group type: EXPERIMENTAL
Intervention: Spironolactone therapy
Number of subjects: 3442

Group type: COMPARATOR
Intervention: Phenogroup 1
Number of subjects: 3442

Group type: COMPARATOR
Intervention: Phenogroup 2
Number of subjects: 3442

Group type: COMPARATOR
Intervention: Phenogroup 3
Number of subjects: 3442
Study: 31039172

Group type: EXPERIMENTAL
Intervention: Aerosol-intradermal vaccination (Group 1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intradermal-aerosol vaccination (Group 2)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Intradermal-intradermal vaccination (Group 3)
Number of subjects: 36
Study: 28820017

Group type: EXPERIMENTAL
Intervention: Nondirective social support
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Directive social support
Number of subjects: 957
Study: 28586612

Group type: EXPERIMENTAL
Intervention: Bipolar TURP
Number of subjects: 220

Group type: COMPARATOR
Intervention: Monopolar TURP
Number of subjects: 220
Study: 24627355

Group type: COMPARATOR
Intervention: Exercise-induced blood flow through IPAVA in older individuals
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hypoxia-induced blood flow through IPAVA in older individuals
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pulmonary arterial systolic pressure during exercise in older individuals
Number of subjects: 30

Group type: COMPARATOR
Intervention: Total pulmonary resistance (TPR) during exercise in older individuals
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Blood flow through IPAVA
Number of subjects: 30
Study: 22990273

Group type: COMPARATOR
Intervention: Conventional weight loss program (n = 30) including regular consultations with a dietitian and physician, and the use of very low‐calorie diets as necessary
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (laparoscopic adjustable gastric banding; n = 30)
Number of subjects: 60
Study: 21121496

Group type: EXPERIMENTAL
Intervention: Helmet with neck and mandible guards
Number of subjects: 10

Group type: COMPARATOR
Intervention: Helmet alone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bare head
Number of subjects: 10
Study: 17066402

Group type: EXPERIMENTAL
Intervention: Bayesian evaluation of group sequential clinical trial designs
Number of subjects: 0
Study: 15598601

Group type: EXPERIMENTAL
Intervention: BWLP+GI education
Number of subjects: 53

Group type: COMPARATOR
Intervention: BWLP
Number of subjects: 53
Study: 11865371

Group type: EXPERIMENTAL
Intervention: Longmire's reconstruction with a pouch
Number of subjects: 41

Group type: COMPARATOR
Intervention: Longmire's reconstruction alone
Number of subjects: 41
Study: 10221742

Group type: EXPERIMENTAL
Intervention: SAS-SMI (Social Adjustment Scale for the Severely Mentally Ill)
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: SAS-SMI
Number of subjects: 670
Study: 8550254

Group type: EXPERIMENTAL
Intervention: 100 g of artificially 13C‐labelled glucose dissolved in 400 ml of water
Number of subjects: 6
Study: 1535716

Group type: EXPERIMENTAL
Intervention: Excimer laser angioplasty (ELA)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Pulsed dye laser angioplasty (DLA)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional balloon angioplasty (BA)
Number of subjects: 96
Study: 6607784

Group type: EXPERIMENTAL
Intervention: Urokinase
Number of subjects: 80

Group type: COMPARATOR
Intervention: Streptokinase
Number of subjects: 80
Study: 31231828

Group type: EXPERIMENTAL
Intervention: Bortezomib consolidation (1.6 mg/m2 IV on days 1, 8, 15, 22)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Observation only
Number of subjects: 357
Study: 28489542

Group type: EXPERIMENTAL
Intervention: Grouping PSO with Personal‐Best‐Position Guidance (GPSO‐PG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current peer algorithms
Number of subjects: 0
Study: 26729193

Group type: EXPERIMENTAL
Intervention: Early endoscopic retrograde cholangiography (ERC) with sphincterotomy
Number of subjects: 232

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 232
Study: 24666552

Group type: EXPERIMENTAL
Intervention: Micronutrient-antioxidant supplementation
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study: 22585352

Group type: EXPERIMENTAL
Intervention: One-screw fixation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Two-screw fixation
Number of subjects: 14
Study: 19793150

Group type: EXPERIMENTAL
Intervention: Barrier-strengthening moisturizing cream as maintenance therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment after initial steroid course
Number of subjects: 0
Study: 17510596

Group type: EXPERIMENTAL
Intervention: Brain Injury Partners CD‐ROM
Number of subjects: 31

Group type: COMPARATOR
Intervention: Alternate CD‐ROM
Number of subjects: 31
Study: 16145305

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate, 10 mg/day
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nomegestrol acetate, 5 mg/day
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dydrogesterone, 10 mg/day
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Micronized progesterone, 200 mg/day
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 100
Study: 12133139

Group type: EXPERIMENTAL
Intervention: Active Care (AC)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Passive Care (PC)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 200
Study: 9486936

Group type: EXPERIMENTAL
Intervention: Lisinopril alone (monotherapy)
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Lisinopril with trichlormethiazide (combination therapy)
Number of subjects: 466
Study: 7965272

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control (normotensive subjects)
Number of subjects: 87
Study: 3315173

Group type: EXPERIMENTAL
Intervention: Pseudomonas vaccine immunotherapy
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Tamoxifen with FAC chemotherapy
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Radiotherapy consolidation
Number of subjects: 133

Group type: COMPARATOR
Intervention: FAC chemotherapy
Number of subjects: 133
Study: 28610482

Group type: EXPERIMENTAL
Intervention: Healthy Lifestyles intervention delivered over approximately 9 months
Number of subjects: 235

Group type: COMPARATOR
Intervention: Telephone-delivered intervention (control)
Number of subjects: 235
Study: 26481811

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (60 μg/d)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study: 25395311

Group type: EXPERIMENTAL
Intervention: IBUNa 2 × 256 mg
Number of subjects: 71

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 71
Study: 22526014

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg administered intravenously prior to surgery
Number of subjects: 34
Study: 19660338

Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia
Number of subjects: 80

Group type: COMPARATOR
Intervention: Cold crystalloid cardioplegia
Number of subjects: 80
Study: 19017409

Group type: EXPERIMENTAL
Intervention: Norepinephrine infusion (n = 16)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion (n = 16)
Number of subjects: 32
Study: 16895622

Group type: EXPERIMENTAL
Intervention: Doxapram 1 mg kg(‐1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Aminophylline 2 mg kg(‐1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline placebo intravenous
Number of subjects: 90
Study: 12752836

Group type: EXPERIMENTAL
Intervention: Very unsteady patients at admission
Number of subjects: 1557

Group type: COMPARATOR
Intervention: Slightly unsteady patients at admission
Number of subjects: 1557

Group type: COMPARATOR
Intervention: Slightly steady patients at admission
Number of subjects: 1557

Group type: COMPARATOR
Intervention: Very steady patients at admission
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: Very unsteady patients who declined before hospitalization
Number of subjects: 1557

Group type: COMPARATOR
Intervention: Slightly unsteady patients who declined before hospitalization
Number of subjects: 1557

Group type: COMPARATOR
Intervention: Slightly steady patients who declined before hospitalization
Number of subjects: 1557

Group type: COMPARATOR
Intervention: Very steady patients who declined before hospitalization
Number of subjects: 1557
Study: 10845343

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBSM) group intervention for 10 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 34
Study: 8979659

Group type: EXPERIMENTAL
Intervention: Timolol maleate 0.25 percent with silicone punctal plugs
Number of subjects: 17

Group type: COMPARATOR
Intervention: Timolol maleate 0.25 percent without silicone punctal plugs
Number of subjects: 17
Study: 1607083

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen via oral route (2 liters/min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supplemental oxygen via nasal cannulas (2 liters/min)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pre-oxygenation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (2 liters/min)
Number of subjects: 0
Study: 2411649

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 488

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 488
Study: 30307129

Group type: EXPERIMENTAL
Intervention: 4-mm implants
Number of subjects: 11

Group type: COMPARATOR
Intervention: 10 or 8-mm long implants
Number of subjects: 11

Group type: COMPARATOR
Intervention: Long implants in augmented bone
Number of subjects: 11
Study: 26721935

Group type: EXPERIMENTAL
Intervention: Eldelumab 25 mg/kg
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Eldelumab 15 mg/kg
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study: 25041577

Group type: EXPERIMENTAL
Intervention: Behavioral migraine management (BMM)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Beta-blocker
Number of subjects: 232
Study: 22060048

Group type: EXPERIMENTAL
Intervention: Maxillary sinus floor augmentation surgery
Number of subjects: 35

Group type: COMPARATOR
Intervention: Non-augmented control sinuses
Number of subjects: 35